BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu H, Liu C, Xu M, Guo M, Xu S, Xie M. Prognostic value of the number of negative lymph nodes in esophageal carcinoma without lymphatic metastasis. Thorac Cancer 2018;9:1129-35. [PMID: 29952086 DOI: 10.1111/1759-7714.12796] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Qi Z, Hu Y, Qiu R, Li J, Li Y, He M, Wang Y. Survival risk prediction model for patients with pT1-3 N0M0 esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes. J Cardiothorac Surg 2021;16:121. [PMID: 33933129 DOI: 10.1186/s13019-021-01503-0] [Reference Citation Analysis]
2 Xiao W, Liang H, Zhang H, Jia R, Yang Y, Wang Y, Tang P, Yu Z. Ratio between negative and positive lymph nodes is a novel prognostic indicator for patients with esophageal cancer: A Surveillance, Epidemiology and End Results database analysis. Thorac Cancer 2020;11:3490-500. [PMID: 33034409 DOI: 10.1111/1759-7714.13688] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wen J, Chen D, Zhao T, Chen J, Zhao Y, Liu D, Wang W, Xu X, Fan M, Chen C, Chen Y. Should the clinical significance of supraclavicular and celiac lymph node metastasis in thoracic esophageal cancer be reevaluated? Thorac Cancer 2019;10:1725-35. [PMID: 31293066 DOI: 10.1111/1759-7714.13144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Haye K, Babu S, Oblein L, Gupta R, Akalin A, Escobar-Hoyos LF, Shroyer KR. Keratin 17 Expression Predicts Poor Clinical Outcome in Patients With Advanced Esophageal Squamous Cell Carcinoma. Appl Immunohistochem Mol Morphol 2021;29:144-51. [PMID: 32554975 DOI: 10.1097/PAI.0000000000000862] [Reference Citation Analysis]
5 Yu L, Zhang XT, Guan SH, Cheng YF, Li LX. The Number of Negative Lymph Nodes is Positively Associated with Survival in Esophageal Squamous Cell Carcinoma Patients in China. Open Med (Wars) 2020;15:152-9. [PMID: 32190739 DOI: 10.1515/med-2020-0023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ding Q, Zhou W, Xue Y, Han X, Yin D, Xue L, Luo J. Comparison of postoperative complications between different operation methods for esophageal cancer. Thorac Cancer 2019;10:1669-72. [PMID: 31245903 DOI: 10.1111/1759-7714.13092] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Guo Q, Zhu J, Wu Y, Wen H, Xia L, Ju X, Ke G, Wu X. Validation of the prognostic value of various lymph node staging systems for cervical squamous cell carcinoma following radical surgery: a single-center analysis of 3,732 patients. Ann Transl Med 2020;8:485. [PMID: 32395529 DOI: 10.21037/atm.2020.03.27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Feng W, Qi Z, Qiu R, Li ZS, Dong SL, Li YK, Hu YP, He M, Wang YX. Risk factors for tumor recurrence in patients with pT3N0M0 thoracic esophageal squamous cell carcinoma after esophagectomy. J Int Med Res 2020;48:300060520977403. [PMID: 33290111 DOI: 10.1177/0300060520977403] [Reference Citation Analysis]
9 He W, Yan Q, Fu L, Han Y. A five-gene signature to predict the overall survival time of patients with esophageal squamous cell carcinoma. Oncol Lett 2019;18:1381-7. [PMID: 31423201 DOI: 10.3892/ol.2019.10449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Zhang H, Xiao W, Ren P, Zhu K, Jia R, Yang Y, Gong L, Yu Z, Tang P. The prognostic performance of the log odds of positive lymph nodes in patients with esophageal squamous cell carcinoma: A population study of the US SEER database and a Chinese single-institution cohort. Cancer Med 2021. [PMID: 34240812 DOI: 10.1002/cam4.4120] [Reference Citation Analysis]